{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:37:29Z","timestamp":1761561449419},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T00:00:00Z","timestamp":1168473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>In July 2001, our Veterans\u2019 Affairs hospital changed its formulary proton pump inhibitor (PPI) from lansoprazole to rabeprazole. All patients previously receiving lansoprazole 30\u2003mg twice daily were switched to rabeprazole 20\u2003mg once daily.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To determine if patients with gastro\u2010oesophageal reflux disease (GERD), who were previously managed on lansoprazole 30\u2003mg twice daily, could be maintained on rabeprazole 20\u2003mg once daily.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>Four hundred and thirty\u2010five patients had received lansoprazole 30\u2003mg twice daily for at least 12\u2003months before the formulary change. Medical records were reviewed for 12\u2003months before and after the formulary change.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 432 men and three women with a mean age of 66.7\u2003years (range: 38\u201391). Two hundred and twelve patients were excluded. Of the remaining 223, 111 (50%) were maintained successfully on rabeprazole 20\u2003mg once daily. Twenty\u2010three (10%) stayed off all acid suppression during follow\u2010up. The number of endoscopies and clinic visits did not significantly change during the follow\u2010up. Fifty\u2010six percent who had erosive oesophagitis failed a dose taper compared with 31% of those with endoscopy\u2010negative GERD (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.025).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Most patients receiving twice daily PPI therapy for GERD could be maintained on once daily PPI or no acid suppression for 12\u2003months of follow\u2010up. Dose reduction was more successful in those without erosive oesophagitis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2007.03248.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T10:57:22Z","timestamp":1279882642000},"page":"709-714","source":"Crossref","is-referenced-by-count":18,"title":["Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro\u2010oesophageal reflux disease associated with a formulary change at a VA medical center"],"prefix":"10.1111","volume":"25","author":[{"given":"G. A.","family":"COT\u00c9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"FERREIRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"ROZENBERG\u2010BEN\u2010DROR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W.","family":"HOWDEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01071906"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200911"},{"key":"e_1_2_6_4_2","first-page":"181","article-title":"pH, healing rate, and symptom relief in patients with GERD","volume":"72","author":"Huang JQ","year":"1999","journal-title":"Yale J Biol Med"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.9.7.624"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309096076"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005548318996"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655200453566"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178669"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1803"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1810"},{"issue":"2","key":"e_1_2_6_12_2","article-title":"Short\u2010term treatment with proton pump inhibitors, H2 receptor antagonists and prokinetics for gastro\u2010esophageal reflux disease\u2010like symptoms and endoscopy negative reflux disease","author":"Van Pinxteren B","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00438.x"},{"key":"e_1_2_6_14_2","article-title":"Rabeprazole is comparable in efficacy to omeprazole in erosive GERD and provides more rapid heartburn relief","volume":"116","author":"Delchier J","year":"1998","journal-title":"Gastroenterology"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05517.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220090-00001"},{"key":"e_1_2_6_17_2","first-page":"353","article-title":"Lansoprazole overutilization: methods for step\u2010down therapy","volume":"9","author":"Pohland CJ","year":"2003","journal-title":"Am J Manag Care"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.03980.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03861.x"},{"key":"e_1_2_6_20_2","first-page":"483","article-title":"Long\u2010term treatment of patients with symptomatic gastroesophageal reflux disease comparing costs and efficacy over 6\u2003month of treatment with nexium on\u2010demand treatment or nexium continuous treatment. An open, randomised multi\u2010center study","volume":"95","author":"Beglinger C","year":"2006","journal-title":"Schweiz Rundsch Med Prax"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-005-1704-y"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00563.x"},{"key":"e_1_2_6_23_2","unstructured":"MorganDG O\u2019MahonyMF O\u2019MahonyWF et\u00a0al.Maintenance Therapy with Continuous and On\u2010Demand Rabeprazole (RAB) 20\u2003mg in Uninvestigated Gastroesophageal Reflux Disease. Abstract Presented at Digestive Diseases Week Los Angeles CA 2006."},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.9.7.624"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00669.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07665.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90531-2"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510263331703"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2007.03248.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2007.03248.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:15:03Z","timestamp":1697393703000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2007.03248.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,22]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1111\/j.1365-2036.2007.03248.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03248.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,22]]}}}